Voss Capital, LLC Exact Sciences Corp Transaction History
Voss Capital, LLC
- $1.07 Billion
- Q1 2025
A detailed history of Voss Capital, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Voss Capital, LLC holds 17,500 shares of EXAS stock, worth $987,350. This represents 0.25% of its overall portfolio holdings.
Number of Shares
17,500Holding current value
$987,350% of portfolio
0.25%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding EXAS
# of Institutions
644Shares Held
155MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$1.01 Billion0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$995 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$705 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$681 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$373 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.98B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...